Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSVtk Gene Therapy in Ovarian Cancer
NCT00005025Phase 2Unknown
- Sponsor
- Iowa Methodist Medical Center
- Start
- Jun 2000
- Modality
- Gene Editing, Gene Silencing, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hsv-tk in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by Iowa Methodist Medical Center. Status: unknown.
02
Drugs
hsv-tk
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00005025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005025.